Navigating the Landscape: GLP-1 Receptor Agonist Availability in GermanyIn the last few years, the pharmaceutical landscape has been changed by a class of medications understood as GLP-1 (Glucagon-like peptide-1) receptor agonists. Initially developed to deal with Type 2 diabetes, these medications have acquired worldwide attention for their substantial efficacy in
